Kazima Tosh

BG Medicine (United States) — United States

Medicine · Health Sciences

3h-index34citations4works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(3), SARS-CoV-2 and COVID-19 Research(3), Clinical practice guidelines implementation(1), Phagocytosis and Immune Regulation(1)

Publications4 total

Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)
Clinical Infectious Diseases·2025· 8 citedOpen Access
91. Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating Pemivibart
Open Forum Infectious Diseases·2025Open Access
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From the CANOPY Clinical Trial
2024· 4 citedOpen Access
Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE)
Open Forum Infectious Diseases·2023· 22 citedOpen Access

Frequent Co-authors

Anna Holmes(4), Anne-Marie Phelan(4), Deepali Gupta(4), Kristin Narayan(4), Pamela Hawn(4), Yong Li(3), Ilker Yalcin(3), Ed Campanaro(3), Peter Schmidt(3), Kathryn Mahoney(3), Claudio Katz(3), Mark A. Wingertzahn(3), Cameron R. Wolfe(2), Jonathan Cohen(2), Natalia Betancourt(2), Myra Popejoy(2), Michael G. Ison(1), Debra F. Weinstein(1), Marta Dobryanska(1), Ellie Hershberger(1)